72 related articles for article (PubMed ID: 2318257)
1. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
de Chaffoy de Courcelles D; De Clerck F
Eur J Pharmacol; 1990 Mar; 188(2-3):161-9. PubMed ID: 2318257
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet effect of catechol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
Chang MC; Chang HH; Wang TM; Chan CP; Lin BR; Yeung SY; Yeh CY; Cheng RH; Jeng JH
PLoS One; 2014; 9(8):e104310. PubMed ID: 25122505
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2 exerts promoting effects on cell proliferation through mediating cyclooxygenase-2 signal in lung adenocarcinoma cells.
Huang RY; Li SS; Guo HZ; Huang Y; Zhang X; Li MY; Chen GG; Zeng X
J Cancer Res Clin Oncol; 2014 Mar; 140(3):375-86. PubMed ID: 24384873
[TBL] [Abstract][Full Text] [Related]
4. ALOX12 mutation in a family with dominantly inherited bleeding diathesis.
Mitsui T; Makino S; Tamiya G; Sato H; Kawakami Y; Takahashi Y; Meguro T; Izumino H; Sudo Y; Norota I; Ishii K; Hayasaka K
J Hum Genet; 2021 Aug; 66(8):753-759. PubMed ID: 33564083
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet therapy: targeting the TxA2 pathway.
Fontana P; Zufferey A; Daali Y; Reny JL
J Cardiovasc Transl Res; 2014 Feb; 7(1):29-38. PubMed ID: 24353037
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin F2α Facilitates Platelet Activation by Acting on Prostaglandin E2 Receptor Subtype EP3 and Thromboxane A2 Receptor TP in Mice.
Kashiwagi H; Yuhki KI; Imamichi Y; Kojima F; Kumei S; Tasaki Y; Narumiya S; Ushikubi F
Thromb Haemost; 2019 Aug; 119(8):1311-1320. PubMed ID: 31129913
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide potentiates platelet responses via toll-like receptor 4-stimulated Akt-Erk-PLA2 signalling.
Lopes Pires ME; Clarke SR; Marcondes S; Gibbins JM
PLoS One; 2017; 12(11):e0186981. PubMed ID: 29136006
[TBL] [Abstract][Full Text] [Related]
8. Protein disulfide isomerase-A1 regulates intraplatelet reactive oxygen species-thromboxane A
Przyborowski K; Kurpinska A; Wojkowska D; Kaczara P; Suraj-Prazmowska J; Karolczak K; Malinowska A; Pelesz A; Kij A; Kalvins I; Watala C; Chlopicki S
J Thromb Haemost; 2022 Jan; 20(1):157-169. PubMed ID: 34592041
[TBL] [Abstract][Full Text] [Related]
9. Thromboxane A2 mediates iron-overload cardiomyopathy in mice through calcineurin-nuclear factor of activated T cells signaling pathway.
Lin H; Li HF; Lian WS; Chen HH; Lan YF; Lai PF; Cheng CF
Circ J; 2013; 77(10):2586-95. PubMed ID: 23856650
[TBL] [Abstract][Full Text] [Related]
10. Effect of Prostanoids on Human Platelet Function: An Overview.
Braune S; Küpper JH; Jung F
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260972
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol Inhibits Metabolism and Affects Blood Platelet Function in Type 2 Diabetes.
Michno A; Grużewska K; Ronowska A; Gul-Hinc S; Zyśk M; Jankowska-Kulawy A
Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458194
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic effects of EV-077: results of an in vitro pilot investigation in healthy volunteers.
Tello-Montoliu A; Rollini F; Desai B; Pasqualino G; Patel R; Sorensen AS; Sakariassen KS; Angiolillo DJ
J Thromb Thrombolysis; 2012 Oct; 34(3):297-9. PubMed ID: 22923024
[No Abstract] [Full Text] [Related]
13. Difluorinated thromboxane A
Allen MF; Hutchinson JL; Keith M; Mallah S; Corey RA; Trory JS; Jing C; Fang H; Wei L; Bennett SH; Aggarwal VK; Mundell SJ; Hers I
Br J Pharmacol; 2024 Jun; ():. PubMed ID: 38840293
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of thromboxane A
Shin JH; Kwon HW; Rhee MH; Park HJ
J Ginseng Res; 2019 Apr; 43(2):236-241. PubMed ID: 30976161
[TBL] [Abstract][Full Text] [Related]
15. Correlation of platelet-derived growth factor and thromboxane A2 expression with platelet parameters and coagulation indices in chronic altitude sickness patients.
Yin Y; Geng H; Cui S; Hua-Ji L
Exp Physiol; 2022 Aug; 107(8):807-812. PubMed ID: 35616548
[TBL] [Abstract][Full Text] [Related]
16. The Role and Regulation of Thromboxane A
Ashton AW; Zhang Y; Cazzolli R; Honn KV
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234768
[TBL] [Abstract][Full Text] [Related]
17. Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath.
Chiang KC; Rizk JG; Nelson DJ; Krishnamurti L; Subbian S; Imig JD; Khan I; Reddy ST; Gupta A
Expert Opin Ther Targets; 2022 Jan; 26(1):13-28. PubMed ID: 35068281
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet properties of Pim kinase inhibition are mediated through disruption of thromboxane A2 receptor signaling.
Unsworth AJ; Bye AP; Sage T; Gaspar RS; Eaton N; Drew C; Stainer A; Kriek N; Volberding PJ; Hutchinson JL; Riley R; Jones S; Mundell SJ; Cui W; Falet H; Gibbins JM
Haematologica; 2021 Jul; 106(7):1968-1978. PubMed ID: 32467143
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Nitric Oxide on Calcium Mobilization and Arachidonic Acid Pathway Activation during Platelet Aggregation with different aggregating agonists.
Banerjee D; Mazumder S; Kumar Sinha A
Int J Biomed Sci; 2016 Mar; 12(1):25-35. PubMed ID: 27127451
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of Kv7.1 channels in thromboxane A2-induced colonic cancer cell proliferation.
Shimizu T; Fujii T; Takahashi Y; Takahashi Y; Suzuki T; Ukai M; Tauchi K; Horikawa N; Tsukada K; Sakai H
Pflugers Arch; 2014 Mar; 466(3):541-8. PubMed ID: 23995773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
